Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes.

about

Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes.

Item

http://www.wikidata.org/entity/Q42012439

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@en

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@nl

type

Item

label

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@en

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@nl

prefLabel

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@en

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@nl

P1476

Lipoprotein-associated Phospho ...... Patients with Type 2 Diabetes.

@en

P2093

Haixia Sun

http://www.w3.org/2001/XMLSchema#string

Jie Sun

http://www.w3.org/2001/XMLSchema#string

Jing Han

http://www.w3.org/2001/XMLSchema#string

Rong Huang

http://www.w3.org/2001/XMLSchema#string

Rongrong Cai

http://www.w3.org/2001/XMLSchema#string

Sai Tian

http://www.w3.org/2001/XMLSchema#string

Shaohua Wang

http://www.w3.org/2001/XMLSchema#string

Wenqing Xia

http://www.w3.org/2001/XMLSchema#string

Xue Dong

http://www.w3.org/2001/XMLSchema#string

Yanjue Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a review

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Mild cognitive impairment: clinical characterization and outcome

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker

Education and the prevalence of dementia and Alzheimer's disease

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Synaptic scaling mediated by glial TNF-alpha

P2888

s41598-017-12515-z

P304

12311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-12515-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28951620

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

P932

5615059

http://www.w3.org/2001/XMLSchema#string